FanconiG.: Das Coeliakiesyndrom bei Angeborener Zystischer Pancreasfibromatose Land Bronchiektasien, Wein med Wchnschr86: 753–756, 1936.
2.
FarberS.: Some Organic Digestive Disturbances in Early Life, J. Michigan Med. Soc.44: 587–594, 1945.
3.
diSant'AgneseP. A., and TalamoR. C.: Pathogenesis and Physiopathology of Cystic Fibrosis of the Pancreas, N. Engl. J. Med.277: 1287–1295, 1343-1352, 1399-1408 (Dec.) 1967.
4.
MatthewsL. W.: A Therapeutic Regimen for Patients With Cystic Fibrosis, J. Pediatr.65: 558–575 (Oct.) 1964.
5.
BrownJ.: Cystic Fibrosis, Med. J. Aust.1: 67–70 (June) 1972.
6.
TreverR. W., and AbrahamsW.: Cystic Fibrosis of the Pancreas, Arch. Intern. Med.106: 253–260 (Aug.) 1960.
7.
ShwachmanH., and KulczyckiL. L.: Long-Term Study of One Hundred Five Patients With Cystic Fibrosis, Amer. J. Dis. Child.96: 6–15 (July) 1958.
8.
JohnasenP. G.: Cystic Fibrosis of the Pancreas. A Generalized Disturbance of Water and Electrolyte Movement in Exocrine Tissues, Lancet1: 455–460, 1968.
9.
LoweC. U.: Cystic Fibrosis of the Pancreas, Pediatrics, edited by BarnettH. L., 15th ed. 1972, Appleton-Century Crofts, N.Y., N.Y., p. 413–430.
10.
DanksD. M.: Genetic Study of Fibrocystic Disease of the Pancreas, Ann. Human Genet.28: 323–356 (May) 1965.
11.
SpockA.: Abnormal Serum Factor in Patients With Cystic Fibrosis of the Pancreas, Pediatr. Res.1: 173–177, 1967.
12.
SanchisJ.: Pulmonary Mucociliary Clearance in Cystic Fibrosis, N. Engl. J. Med.288: 651–654 (Mar.) 1973.
13.
MearnsM. B.: Bacterial Flora of Respiratory Tract in Patients With Cystic Fibrosis, 1950-1971, Arch. Dis. Child.47: 902–907 (Dec.) 1972.
14.
BowdenD. H.: Cor Pulmonale in Cystic Fibrosis, Amer. J. Med.38: 226–232 (Feb.) 1965.
15.
GoldringR. M.: Cor Pulmonale in Cystic Fibrosis of the Pancreas, Circulation24: 942, 1961.
16.
GoldringR. M.: Pulmonary Hypertension and Cor Pulmonale in Cystic Fibrosis of the Pancreas. J. Pediatr.65: 501–524 (Oct.) 1964.
17.
BotelhoS. Y.: Tear Sodium. Potassium Chloride and Calcium at Various Flow Rates: Children With Cystic Fibrosis and Unaffected Siblings With and Without Corneal Staining, J. Pediatr.83: 601–606 (Oct.) 1973.
18.
HolsclawD. S.: Meconium Ileus: A 20-Year Review of 109 Cases, Amer. J. Dis. Child.109: 101–113 (Feb.) 1965.
19.
DonnisonA. B.: A Review of 164 Children With Meconium Ileus Seen at the Children's Hospital Medical Center, Boston, Pediatrics37: 833–850 (May) 1966.
ThomaidisT. S., and AreyJ. B.: The Intestinal Lesions in Cystic Fibrosis of the Pancreas, J. Pediatr.63: 444–453 (Sept.) 1963.
22.
diSant'AgneseP. A.: Fibrocystic Disease of the Pancreas With Normal or Partial Pancreatic Function: Current Views on Pathogenesis and Diagnosis, Pediatrics15: 683–696 (May) 1955.
23.
ShwachmanH.: Cystic Fibrosis of the Pancreas With Varying Degrees of Pancreatic Insufficiency, Amer. J. Dis. Child.92: 347–368, 1956.
24.
DerenJ. J.: Malabsorption of Crystalline Vitamin B12 in Cystic Fibrosis, N. Engl. J. Med.288: 949–950 (May) 1973.
25.
SimopululosA. P.: Calcium Metabolism and Parathyroid Function in Cystic Fibrosis, Cystic Fibrosis Club Conference, Atlantic City, New Jersey (Apr. 28) 1971, p. 13.
26.
ReemstmaK.: Cystic Fibrosis of the Pancreas: Intestinal Absorption of Fat and Fatty Acid Labeled With I131Pediatrics22: 525–532 (Sept.) 1958.
27.
KulczyckiL. L., and ShwachmanH.: Studies in Cystic Fibrosis of the Pancreas: Occurrence of Rectal Prolapse. N. Engl. J. Med.259: 409–412 (Aug.) 1958.
28.
SharpH. L., and WarwickW. J.: Hepatic Function and Structure in Cystic Fibrosis, Cystic Fibrosis Club Conference, Atlantic City, New Jersey (Apr. 30) 1968, p. 4–5.
29.
diSant'AgneseP. A., and BlancW. A.: A Distinctive Type of Biliary Cirrhosis of the Liver Associated With Cystic Fibrosis of the Pancreas: Recognition Through Signs of Portal Hypertension, Pediatrics18: 387–409 (Sept.) 1956.
30.
DarlingR. C.: Electrolyte Abnormalities of the Sweat in Fibrocystic Disease of the Pancreas, Amer. J. Med. Sci.225: 67–70 (Jan.) 1953.
31.
MearnsM. B.: Bacterial Flora of Respiratory Tract in Patients With Cystic Fibrosis, 1950-1971. Arch. Dis. Child.47: 902–907 (Dec.) 1972.
32.
MayJ. R.: Bacterial Infection in Cystic Fibrosis, Arch. Dis. Child.47: 908–913 (Dec.) 1972.
33.
BurnsM. W., and MayJ. R.: Bacterial Precipitins in Serum of Patients With Cystic Fibrosis, Lancet1: 270–272 (Feb.) 1968.
34.
KilbournJ. P.: Infection in Cystic Fibrosis, Lancet2: 878–879 (Oct.) 1970.
35.
LawsonD. N.: Contribution to Panel Discussion on Microbiology and Chemotherapy of the Respiratory Tract in Cystic Fibrosis, In Proceedings of the 5th International Cystic Fibrosis Conference, Cambridge (Sept. 1969) p. 225, ed. by LawsonD., Cystic Fibrosis Research Trust, London.
36.
DoggettR. G., and HarrisonG. M.: Pseudomonas aeruginosa: Immune Status in Patients With Cystic Fibrosis. Infec. Immun.6: 628–635 (Oct.) 1972.
37.
DiazF., MosovichL., and NeterI.: Serogroups of Pseudomonas aeruginosa and the Immune Response of Patients With Cystic Fibrosis, J. Inf. Dis.121: 296 (Mar.) 1970.
38.
diSant'AgneseP. A., and VidaurettaA. M.: Cystic Fibrosis of the Pancreas, J. Amer. Med. Assoc.172: 2065–2072 (Apr.) 1960.
SolomonsC. C.: The use of Buffered 1-Arginine in the Treatment of Cystic Fibrosis, Pediatrics47: 384–390 (Feb.) 1971.
41.
SolomonsC. C.: L-Arginine, the Sickling Phenomenon, and Cystic Fibrosis, Pediatrics49: 933 (June) 1972.
42.
FeatherE. A., and RusselG.: Effects of Tolazoline Hydrochloride on Sputum Viscosity in Cystic Fibrosis, Thorax25: 732–736 (Nov.) 1970.
43.
ChangN., and LevisonH.: The Effect of a Nebulized Bronchodilator Administered With or Without Intermittent Positive Pressure Breathing on Ventilatory Function in Children With Cystic Fibrosis and Asthma, Amer. Rev. Resp. Dis.106: 867–872 (Dec.) 1972.
44.
DolanT. F., and GibsonL. E.: Complications of Iodide Therapy in Patients With Cystic Fibrosis, J. Pediatr.79: 684–687 (Oct.) 1971.
45.
SmithC. B.: Use of Gentamicin in Combination With Other Antibiotics, J. Infect. Dis.119: 370–377 (Apr.-May) 1969.
46.
MarksM. I.: Carbenicillin and Gentamicin: Pharmacologic Studies in Patients With Cystic Fibrosis and Pseudomonas Pulmonary Infections, J. Pediatr.79: 822–828 (Nov.) 1971.
47.
BoxerbaumB.: Use of Gentamicin in Children With Cystic Fibrosis, J. Infect. Dis.129 Suppl.: 293–295 (Dec.) 1971.
48.
PhairJ. P.: Carbenicillin Treatment of Pseudomonas Pulmonary Infection, J. Infect. Dis.120: 22–25 (July) 1970.
49.
HuangN. N.: Carbenicillin in Patients With Cystic Fibrosis: Clinical Pharmacology and Therapeutic Evaluation, J. Pediatr.78: 338–345 (Feb.) 1971.
50.
RaeburnJ. A., and DevineJ. D.: Clindamycin Levels in Sputum in a Patient With Purulent Chest Disease Due to Cystic Fibrosis, Postgrad. Med. J.47: 366–367 (Jan.) 1971.
51.
LittmanA., and HanscomD. H.: Current Concepts: Pancreatic Extracts, N. Engl. J. Med.281: 201–204 (July) 1969.
52.
MatthewsL. W., and SpectorS.: Breakthrough in Cystic Fibrosis, Pediatrics27: 351, 1961.
53.
NoblettH. R.: Treatment of Uncomplicated Meconium Ileus by Gastrografin Enema: a Preliminary Report, J. Pediatr. Surg.4: 190–197 (Apr.) 1969.
54.
WaggetJ.: The Non-Operative Treatment of Meconium Ileus by Gastrografin Enema, J. Pediatr.77: 407–411 (Apr.) 1970.
55.
MeekerI. A., and KincannotW. N.: Acetylcysteine Used to Liquify Meconium Causing Intestinal Obstruction in the Newborn. Surgery56: 419–425 (Aug.) 1964.
56.
BowringA. C.: The Use of Solvents in the Intestinal Manifestations of Mucoviscidosis, J. Pediatr. Surg.5: 338–343 (June) 1970.
57.
GraceyM.: Treatment of Abdominal Pain in Cystic Fibrosis by Oral Administration of N-Acetyl Cysteine, Arch. Dis. Child.44: 404–405 (June) 1969.
58.
SpockA.: Abnormal Serum Factor in Patients With Cystic Fibrosis of the Pancreas, Pediatr. Res.1: 173–177, 1967.